Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.

Carlet, Jean; Payen, Didier; Opal, Steven M

Carlet, Jean; Payen, Didier; Opal, Steven M.

Carlet J; World Alliance Against Antibiotic Resistance, 94000 Créteil, France. Electronic address: jeancarlet@gmail.com.
Payen D; Paris 7 University, Paris, France.
Opal SM; Infectious Disease Division, Alpert Medical School of Brown University, Providence, RI, USA.

Lancet ; 396(10259): e61-e62, 2020 10 24.

Article in English | MEDLINE | ID: covidwho-1337021

Subject(s)

COVID-19; Respiratory Distress Syndrome; Sepsis; Humans; Respiratory Distress Syndrome/chemically induced; Respiratory Distress Syndrome/drug therapy; SARS-CoV-2; Sepsis/drug therapy; Steroids

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Distress Syndrome / Sepsis / COVID-19 Limits: Humans Language: English Journal: Lancet Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google